New White Paper from Claritas Rx Entitled “Quantifying Connection: Measuring Partner Impact and CRM ROI Across the Enterprise” Now Available

Claritas Rx, the patient journey experts, announced the availability of a new white paper entitled “Quantifying Connection: Measuring Partner Impact and CRM ROI Across the Enterprise.” The paper reveals that an omnichannel CRM, purpose-built for Patient Services teams and their partners (SPs, hubs) can reduce overall time to fill, increase fill rates and drive more patient-months on therapy with greater treatment value.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251103153386/en/

“In a real-world analysis across PBM-owned SPs, independent SPs, and hubs, centralized CRM workflows–those that unify partner activities, patient data, and case management into a single coordinated platform–produced higher prescription fill rates, particularly in high-risk and delayed patient cohorts, while slashing partner response times to less than 24 hours,” said Karishma Desai, Solutions Consulting Engineer at Claritas Rx and one of the authors of the paper.

The white paper reviews the challenges current CRMs pose to Patient Services teams at life sciences companies and explores how a CRM purpose-built for these teams and their partners can significantly improve outcomes and ROI. A Patient Services Omnichannel CRM is an integrated case management and engagement platform designed for healthcare and pharmaceutical brands to optimize patient support and access workflows. It unifies patient-level data, field activities, and partner interactions within a single HIPAA-compliant system, providing real-time case visibility and enabling coordinated care across multiple communication channels.

“In a real-world analysis across PBM-owned SPs, independent SPs, and hubs, centralized CRM workflows–those that unify partner activities, patient data, and case management into a single coordinated platform–produced higher prescription fill rates, particularly in high-risk and delayed patient cohorts, while slashing partner response times to less than 24 hours,” said Karishma Desai, Solutions Consulting Engineer at Claritas Rx and one of the authors of the paper.

Patient Services and Market Access executives interested in the paper can access it here.

For those interested in delving deeper in the benefits of an omnichannel, purpose-built Patient Services CRM, a webinar entitled “The CRM Gamechanger: Maximize Engagement and ROI” will be held on Thursday, December 11 at 1 p.m. ET (10 a.m. PT). The webinar will be hosted by both authors of the paper, Ms. Desai and Juhee Sung-Schenck, Principal Data Scientist at Claritas Rx.

Members of the media can contact Emily Brennan, EBrennan@ClaritasRx.com, to register for the webinar and receive a copy of the white paper.

About Claritas Rx

Based in South San Francisco, CA, Claritas Rx helps rare disease and specialty brands remove the barriers that keep patients from accessing and staying on the treatments they need. By uniting the most complete view of the patient journey with purpose-built technologies, we predict and resolve access challenges before they disrupt care. Our intelligent solutions combine advanced analytics, real-world data, AI, and in-line CRM capabilities to increase start and refill rates, reduce abandonment, and improve brand performance. For more information, visit www.ClaritasRx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251103153386/en/

An omnichannel CRM, purpose-built for Patient Services teams and their partners (SPs, hubs) can reduce overall time to fill, increase fill rates and drive more patient-months on therapy with greater treatment value.